EP Biocomposites enters water body conservation partnership

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • EP Biocomposites signs strategic collaboration with Malligavad Foundation
  • Company acts as execution partner; foundation serves as technical advisor
  • Scope includes Goa, Konkan Division, and Karnataka coastal districts
  • No upfront monetary consideration paid under the agreement
  • Focus on water body rejuvenation and eco-restoration projects
powered bylight_fuzz_icon
52232820

*this image is generated using AI for illustrative purposes only.

EP Biocomposites Limited has entered into a strategic collaboration and consultancy agreement with the Malligavad Foundation and Anand Malligavad, known as the 'Lakeman of India'. The partnership aims to combine expertise for the conservation of water bodies across designated geographical territories in India.

Under the agreement, EP Biocomposites will act as the execution partner, while the Malligavad Foundation and Anand Malligavad will serve as the exclusive technical advisor. The collaboration focuses on rejuvenating lakes, creeks, wetlands, and other water bodies, along with water conservation, effluent treatment, eco-restoration, and associated civil or environmental engineering initiatives.

Geographic Scope and Operational Details

The collaboration covers specific domestic regions, extending the company's aqua division capabilities. The scope of business operations includes:

  • The entire state of Goa
  • Konkan Division, including coastal districts of Sindhudurg, Ratnagiri, and Raigad
  • Coastal and Northern districts of Karnataka, including Mangalore (Dakshina Kannada), Udupi, Karwar (Uttara Kannada), Belgaum (Belagavi), Hubli, and Dharwad

The agreement is classified as a domestic initiative. It is not a related party transaction, and neither the promoter nor promoter group companies hold any interest in the entity being collaborated with. The Malligavad Foundation is registered as a Section 8 company.

Financial Terms and Strategic Rationale

The deal structure involves no immediate cash outflow for EP Biocomposites. The rationale behind the partnership is to leverage the technical expertise of the foundation to enhance the company's environmental engineering offerings.

Particular Details
Collaboration Partner Malligavad Foundation and Anand Malligavad
Role of Company Execution Partner
Role of Partner Exclusive Technical Advisor
Consideration No upfront monetary consideration paid
Nature of Agreement Strategic Collaboration & Consultancy
Related Party Status Not a related party transaction

This strategic move allows the parties to work together on projects that align with the company's existing aqua division. By securing an exclusive technical advisor, EP Biocomposites aims to strengthen its position in environmental conservation projects within the specified geographic boundaries without incurring upfront capital expenditure.

Historical Stock Returns for EP Biocomposites

1 Day5 Days1 Month6 Months1 Year5 Years
-8.31%0.0%0.0%+7.17%-29.64%-46.50%

How will EP Biocomposites structure its revenue model for these projects given the absence of upfront consideration?

What specific government tenders or municipal contracts in Goa and Karnataka are expected to benefit from this exclusive technical partnership?

How does this collaboration impact EP Biocomposites' competitive positioning against established environmental engineering firms in the coastal regions?

Ep Biocomposites wins Rs 0.92 crore work order from Beleza by the Beach

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • Ep Biocomposites secured a Rs 0.92 crore work order for a 70 KLD Sewage Treatment Plant from Beleza by the Beach.
  • The order is the sole disclosure in the last three fiscal quarters, representing 100% of recent order inflow.
  • TTM Revenue and Net Profit are reported as 0.0 Cr in the provided context, limiting immediate comparative analysis.
  • The project has a completion deadline of April 30, 2027, with no other working capital metrics provided for assessment.
powered bylight_fuzz_icon
51993804

*this image is generated using AI for illustrative purposes only.

Ep Biocomposites has received a confirmed work order worth Rs 0.92 crore from Beleza by the Beach for the supply, installation, testing, and commissioning of a Sewage Treatment Plant.

Order In Financial Context

The disclosed order value of Rs 0.92 crore (Rs 92.04 lakh) is classified as "Significant" under regulatory norms, indicating its materiality to the company's current operational scale. Given that the Trailing 12-Month Revenue is reported as 0.0 Cr in the provided fundamental context, calculating a standard book-to-bill ratio or percentage of quarterly revenue is not analytically feasible using the provided data points; however, the order represents a firm contractual commitment. The total disclosed order book consists solely of this single contract, as no other orders were disclosed in the last three fiscal quarters. This single order constitutes the entirety of the visible backlog for the period analyzed.

Company Order Track Record

The company has not disclosed any other order wins in the last three fiscal quarters. The current order is the sole entry in the recent order history provided.

Quarter Total Order Inflow (Rs Cr) Key Awarding Entities
Q4FY27 (Apr-Jun 2027)* 0.92 Beleza by the Beach

Note: The order date is listed as 30.04.2027. The inflow velocity is currently defined by this single disclosure.

Execution And Revenue Quality

The provided financial data indicates a Trailing 12-Month Revenue of 0.0 Cr and Net Profit of 0.0 Cr. Consequently, there is no historical quarterly revenue or OPM trend available in the input to assess execution quality against this new order. The absence of reported revenue in the TTM period suggests either a reporting lag, a specific accounting treatment not detailed here, or a period of minimal recognized revenue prior to this filing.

Revenue Growth - Order Wins Translating To Revenue

The standalone annual P&L data shows a mixed growth trajectory over the last five years. Revenue growth was +13.8% in FY26, following +3.2% in FY25 and +60.9% in FY24. Profit growth was +41.5% in FY26, recovering from -10.3% in FY25. The recent order win adds to the order book, but its impact on future annual revenue figures will depend on execution timelines and recognition policies which are not detailed beyond the completion date of April 30, 2027.

Working Capital And Execution Capacity

Data regarding Current Ratio, Total Liabilities/Equity, Operating Cashflow, and Free Cashflow is [data not available] in the provided input. Therefore, an assessment of liquidity to execute the project or the conversion of backlog into cash cannot be performed based on the supplied figures.

What To Watch

  • Execution Timeline: The contract specifies a completion date of 30.04.2027. Monitor interim updates on mobilization and installation progress leading up to this deadline.
  • Revenue Recognition: With TTM revenue at 0.0 Cr, watch for the first quarter where this order contributes to reported top-line numbers.
  • Client Concentration: The single client, Beleza by the Beach, accounts for 100% of the disclosed order book in the last three quarters.
  • Order Book Expansion: Monitor subsequent filings for additional order wins to assess if this is an isolated event or part of a broader pipeline recovery.

Key Observations

  • Backlog signal: The total disclosed order book is Rs 0.92 crore, derived from a single contract. At this level, the binding constraint is the acquisition of further orders rather than capacity utilization.
  • Valuation check (as of 26 Sep 2026): P/E of 11.1x against ROCE of 16.24%. The valuation appears to price in stability, though the low market cap of Rs 16.20 crore indicates high sensitivity to individual contract outcomes.
  • Client concentration: A single client, Beleza by the Beach, accounts for 100% of the recently disclosed order inflow.

Historical Stock Returns for EP Biocomposites

1 Day5 Days1 Month6 Months1 Year5 Years
-8.31%0.0%0.0%+7.17%-29.64%-46.50%

More News on EP Biocomposites

Must Read Next

Earnings

Sai Silks Q2FY27 Results: Revenue at ₹434 crore, opens 4 stores 1 hr ago
Sedemac Mechatronics Latest Results: ECU sales up 37.5% YoY to 1,452,867 units 1 hr ago

Stocks

Studds Accessories receives occupation certificate for Faridabad Facility-V 1 hr ago
no imag found
Maharashtra FDA cancels Cipla unit's drug sale licence over violations 1 hr ago
Maharashtra GST officials search Sudarshan Chemical offices under Section 67 1 hr ago
1 Year Returns:-29.64%